NCT02010632View on ClinicalTrials.gov

Comparative Pharmacodynamics and Pharmacokinetics Study of Generic and Reference Clopidogrel Products

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

August 31, 2013

Primary Completion Date

October 31, 2014

Study Completion Date

December 31, 2014

Conditions
Pharmacodynamics
Interventions
DRUG

Generic clopidogrel product Apolets®

"* Clopidogrel 75 mg once daily for 7 days~* Blood collection at 0 (before dosing), 1, 2, 4, 6, 8, 12, 24 hours after the last dose, administered at day 7"

DRUG

Original clopidogrel product Plavix®

"* Clopidogrel 75 mg once daily for 7 days~* Blood collection at 0 (before dosing), 1, 2, 4, 6, 8, 12, 24 hours after the last dose, administered at day 7"

Trial Locations (1)

40000

Faculty of Medicine, Khon Kaen University, Khonkaen

All Listed Sponsors
lead

Khon Kaen University

OTHER

NCT02010632 - Comparative Pharmacodynamics and Pharmacokinetics Study of Generic and Reference Clopidogrel Products | Biotech Hunter | Biotech Hunter